An update on the impact of postnatal systemic corticosteroids on mortality and cerebral palsy in preterm infants: Effect modification by risk of bronchopulmonary dysplasia

Journal of Pediatrics

Volumn 165, Issue 6, 2014, Pages 1258-1260

  Doyle, Lex W ^a,b   Halliday, Henry L ^c   Ehrenkranz, Richard A ^d   Davis, Peter G ^a,b   Sinclair, John C ^e  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ARTICLE; ARTIFICIAL VENTILATION; ATTRIBUTABLE RISK; CEREBRAL PALSY; CONTROLLED STUDY; CORTICOSTEROID THERAPY; HEALTH IMPACT ASSESSMENT; HUMAN; INCIDENCE; INFANT MORTALITY; LUNG DYSPLASIA; PREMATURITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT OUTCOME; BRONCHOPULMONARY DYSPLASIA; MORTALITY; RISK ASSESSMENT;

ADRENAL CORTEX HORMONES; BRONCHOPULMONARY DYSPLASIA; CEREBRAL PALSY; EFFECT MODIFIER, EPIDEMIOLOGIC; HUMANS; INFANT, PREMATURE; RISK ASSESSMENT;

EID: 84912564277     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2014.07.049     Document Type: Article

References (38)

1. S.B. Demauro, K. Dysart, and H. Kirpalani Stopping the swinging pendulum of postnatal corticosteroid use J Pediatr 164 2014 9 11
2. L.W. Doyle, H.L. Halliday, R.A. Ehrenkranz, P.G. Davis, and J.C. Sinclair Impact of postnatal systemic corticosteroids on mortality and cerebral palsy in preterm infants: effect modification by risk for chronic lung disease Pediatrics 115 2005 655 661
3. L.W. Doyle, R.A. Ehrenkranz, and H.L. Halliday Early (<8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants Cochrane Database Syst Rev 5 2014 CD001146
4. L.W. Doyle, R.A. Ehrenkranz, and H.L. Halliday Late (>7 days) postnatal corticosteroids for chronic lung disease in preterm infants Cochrane Database Syst Rev 5 2014 CD001145
5. R.M. Harbord, and J.P. Higgins Meta-regression in Stata Stata J 8 2008 493 519
6. R.J. Sanders, C. Cox, D.L. Phelps, and R.A. Sinkin Two doses of early intravenous dexamethasone for the prevention of bronchopulmonary dysplasia in babies with respiratory distress syndrome Pediatr Res 36 1994 122 128
7. E.S. Shinwell, M. Karplus, E. Zmora, D. Reich, A. Rothschild, and S. Blazer Failure of early postnatal dexamethasone to prevent chronic lung disease in infants with respiratory distress syndrome Arch Dis Child Fetal Neonatal Ed 74 1996 F33 F37
8. E.S. Shinwell, M. Karplus, D. Reich, Z. Weintraub, S. Blazer, and D. Bader Early postnatal dexamethasone treatment and increased incidence of cerebral palsy Arch Dis Child Fetal Neonatal Ed 83 2000 F177 F181
9. N.V. Subhedar, S.W. Ryan, and N.J. Shaw Open randomised controlled trial of inhaled nitric oxide and early dexamethasone in high risk preterm infants Arch Dis Child Fetal Neonatal Ed 77 1997 F185 F190
10. T.F. Yeh, Y.J. Lin, W.S. Hsieh, H.C. Lin, C.H. Lin, and J.Y. Chen Early postnatal dexamethasone therapy for the prevention of chronic lung disease in preterm infants with respiratory distress syndrome: a multicenter clinical trial Pediatrics 100 1997 E3
11. T.F. Yeh, Y.J. Lin, H.C. Lin, C.C. Huang, W.S. Hsieh, and C.H. Lin Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity N Engl J Med 350 2004 1304 1313
12. C. Romagnoli, E. Zecca, G. Vento, M.P. De Carolis, P. Papacci, and G. Tortorolo Early postnatal dexamethasone for the prevention of chronic lung disease in high-risk preterm infants Intensive Care Med 25 1999 717 721
13. C. Romagnoli, E. Zecca, R. Luciano, G. Torrioli, and G. Tortorolo Controlled trial of early dexamethasone treatment for the prevention of chronic lung disease in preterm infants: a 3-year follow-up Pediatrics 109 2002 e85
14. C. Romagnoli, E. Zecca, G. Vento, L. Maggio, P. Papacci, and G. Tortorolo Effect on growth of two different dexamethasone courses for preterm infants at risk of chronic lung disease. A randomized trial Pharmacology 59 1999 266 274
15. C. Romagnoli, E. Zecca, R. Luciano, G. Torrioli, and G. Tortorolo A three-year follow-up of preterm infants after moderately early treatment with dexamethasone Arch Dis Child Fetal Neonatal Ed 87 2002 F55 F58
16. K.L. Watterberg, J.S. Gerdes, K.L. Gifford, and H.M. Lin Prophylaxis against early adrenal insufficiency to prevent chronic lung disease in premature infants Pediatrics 104 1999 1258 1263
17. R.A. Sinkin, H.S. Dweck, M.J. Horgan, K.J. Gallaher, C. Cox, and W.M. Maniscalco Early dexamethasone-attempting to prevent chronic lung disease Pediatrics 105 2000 542 548
18. A.R. Stark, W.A. Carlo, J.E. Tyson, L.A. Papile, L.L. Wright, and S. Shankaran Adverse effects of early dexamethasone in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network N Engl J Med 344 2001 95 101
19. A.R. Stark, W.A. Carlo, B.R. Vohr, L.A. Papile, S. Saha, and C.R. Bauer Death or neurodevelopmental impairment at 18 to 22 months corrected age in a randomized trial of early dexamethasone to prevent death or chronic lung disease in extremely low birth weight infants J Pediatr 164 2014 34 39.e2
20. J.J. Cummings, D.B. D'Eugenio, and S.J. Gross A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia N Engl J Med 320 1989 1505 1510
21. S.J. Gross, R.D. Anbar, and B.B. Mettelman Follow-up at 15 years of preterm infants from a controlled trial of moderately early dexamethasone for the prevention of chronic lung disease Pediatrics 115 2005 681 687
22. M.A. Kari, K. Heinonen, R.S. Ikonen, M. Koivisto, and K.O. Raivio Dexamethasone treatment in preterm infants at risk for bronchopulmonary dysplasia Arch Dis Child 68 1993 566 569
23. S. Mieskonen, M. Eronen, L.P. Malmberg, M. Turpeinen, M.A. Kari, and M. Hallman Controlled trial of dexamethasone in neonatal chronic lung disease: an 8-year follow-up of cardiopulmonary function and growth Acta Paediatr 92 2003 896 904
24. B.S. Brozanski, J.G. Jones, C.H. Gilmour, M.J. Balsan, R.L. Vazquez, and B.A. Israel Effect of pulse dexamethasone therapy on the incidence and severity of chronic lung disease in the very low birth weight infant J Pediatr 126 1995 769 776
25. D. Hofkosh, B.S. Brozanski, M.D. Edwards, L.A. Williams, J.G. Jones, and K.P. Cheng One-year outcome of infants treated with pulse dexamethasone for prevention of BPD Pediatr Res 37 1995 259A
26. L. Kovacs, G.M. Davis, D. Faucher, and A. Papageorgiou Efficacy of sequential early systemic and inhaled corticosteroid therapy in the prevention of chronic lung disease of prematurity Acta Paediatr 87 1998 792 798
27. J.M. Kothadia, T.M. O'Shea, D. Roberts, S.T. Auringer, R.G. Weaver III, and R.G. Dillard Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants Pediatrics 104 1999 22 27
28. T.M. O'Shea, L.K. Washburn, P.A. Nixon, and D.J. Goldstein Follow-up of a randomized, placebo-controlled trial of dexamethasone to decrease the duration of ventilator dependency in very low birth weight infants: neurodevelopmental outcomes at 4 to 11 years of age Pediatrics 120 2007 594 602
29. M. Durand, M.E. Mendoza, P. Tantivit, A. Kugelman, and C. McEvoy A randomized trial of moderately early low-dose dexamethasone therapy in very low birth weight infants: dynamic pulmonary mechanics, oxygenation, and ventilation Pediatrics 109 2002 262 268
30. F.J. Walther, R.D. Findlay, and M. Durand Adrenal suppression and extubation rate after moderately early low-dose dexamethasone therapy in very preterm infants Early Hum Dev 74 2003 37 45
31. K.L. Watterberg, J.S. Gerdes, C.H. Cole, S.W. Aucott, E.H. Thilo, and M.C. Mammel Prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia: a multicenter trial Pediatrics 114 2004 1649 1657
32. K.L. Watterberg, M.L. Shaffer, M.J. Mishefske, C.L. Leach, M.C. Mammel, and R.J. Couser Growth and neurodevelopmental outcomes after early low-dose hydrocortisone treatment in extremely low birth weight infants Pediatrics 120 2007 40 48
33. O. Peltoniemi, M.A. Kari, K. Heinonen, T. Saarela, K. Nikolajev, and S. Andersson Pretreatment cortisol values may predict responses to hydrocortisone administration for the prevention of bronchopulmonary dysplasia in high-risk infants J Pediatr 146 2005 632 637
34. O.M. Peltoniemi, A. Lano, R. Puosi, A. Yliherva, F. Bonsante, and M.A. Kari Trial of early neonatal hydrocortisone: two-year follow-up Neonatology 95 2009 240 247
35. L.W. Doyle, P.G. Davis, C.J. Morley, A. McPhee, and J.B. Carlin Low-dose dexamethasone facilitates extubation among chronically ventilator-dependent infants: a multicenter, international, randomized, controlled trial Pediatrics 117 2006 75 83
36. L.W. Doyle, P.G. Davis, C.J. Morley, A. McPhee, and J.B. Carlin Outcome at 2 years of age of infants from the DART study: a multicenter, international, randomized, controlled trial of low-dose dexamethasone Pediatrics 119 2007 716 721
37. F. Bonsante, G. Latorre, S. Iacobelli, V. Forziati, N. Laforgia, and L. Esposito Early low-dose hydrocortisone in very preterm infants: a randomized, placebo-controlled trial Neonatology 91 2007 217 221
38. M.M. Laughon, J.C. Langer, C.L. Bose, P.B. Smith, N. Ambalavanan, and K.A. Kennedy Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants Am J Respir Crit Care Med 183 2011 1715 1722